Literature DB >> 25680557

Haploinsufficiency of the miR-873/miR-876 microRNA cluster is associated with craniofacial abnormalities.

Costas Koufaris1, Gregoris Papagregoriou2, Ludmila Kousoulidou1, Maria Moutafi1, Maithé Tauber3, Béatrice Jouret3, Isabelle Kieffer4, Constantinos Deltas2, George A Tanteles5, Violetta Anastasiadou6, Philippos C Patsalis7, Carolina Sismani8.   

Abstract

MicroRNA haploinsufficiency has been associated with developmental defects in only a limited number of cases. Here we report a de novo genomic microdeletion that includes the LINGO2 gene as well as two microRNA genes, MIR873 and MIR876, in a patient with craniofacial abnormalities - in particular macrocephaly and hypertelorism - and learning difficulties. Subsequent analysis revealed that the microRNAs affected by this de novo microdeletion form a mammalian-lineage, neuronal tissue-enriched cluster. In addition, bioinformatic analysis and experimental data indicate that miR-873 is involved in the regulation of the Hedgehog signaling, an essential pathway involved in craniofacial patterning and differentiation. Collectively these observations are consistent with a role of the miR-873/miR-876 microRNA cluster in physiological cranial bone development and indicate that mutations affecting these microRNAs could be a rare cause of developmental defect in humans.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Craniofacial; Developmental defect; Haploinsufficiency; Hedgehog; miR-873; miR-876

Mesh:

Substances:

Year:  2015        PMID: 25680557     DOI: 10.1016/j.gene.2015.02.018

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  MicroRNA-1907 enhances atherosclerosis-associated endothelial cell apoptosis by suppressing Bcl-2.

Authors:  Jin Zhao; Shu-Lin Ou; Wei-You Wang; Chang Yan; Lu-Xiang Chi
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

2.  De novo variants in FBXO11 cause a syndromic form of intellectual disability with behavioral problems and dysmorphisms.

Authors:  Sandra Jansen; Ilse M van der Werf; A Micheil Innes; Alexandra Afenjar; Pankaj B Agrawal; Ilse J Anderson; Paldeep S Atwal; Ellen van Binsbergen; Marie-José van den Boogaard; Lucia Castiglia; Zeynep H Coban-Akdemir; Anke van Dijck; Diane Doummar; Albertien M van Eerde; Anthonie J van Essen; Koen L van Gassen; Maria J Guillen Sacoto; Mieke M van Haelst; Ivan Iossifov; Jessica L Jackson; Elizabeth Judd; Charu Kaiwar; Boris Keren; Eric W Klee; Jolien S Klein Wassink-Ruiter; Marije E Meuwissen; Kristin G Monaghan; Sonja A de Munnik; Caroline Nava; Charlotte W Ockeloen; Rosa Pettinato; Hilary Racher; Tuula Rinne; Corrado Romano; Victoria R Sanders; Rhonda E Schnur; Eric J Smeets; Alexander P A Stegmann; Asbjørg Stray-Pedersen; David A Sweetser; Paulien A Terhal; Kristian Tveten; Grace E VanNoy; Petra F de Vries; Jessica L Waxler; Marcia Willing; Rolph Pfundt; Joris A Veltman; R Frank Kooy; Lisenka E L M Vissers; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2019-01-24       Impact factor: 4.246

Review 3.  Regulatory Role of MicroRNAs in Brain Development and Function.

Authors:  Christos Yapijakis
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  MiR-876-5p suppresses epithelial-mesenchymal transition of lung cancer by directly down-regulating bone morphogenetic protein 4.

Authors:  Liang Bao; Lei Lv; Jinping Feng; Yuyu Chen; Xinhua Wang; Shuguang Han; Hongqing Zhao
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

5.  Autism-associated miR-873 regulates ARID1B, SHANK3 and NRXN2 involved in neurodevelopment.

Authors:  Jing Lu; Yan Zhu; Sarah Williams; Michelle Watts; Mary A Tonta; Harold A Coleman; Helena C Parkington; Charles Claudianos
Journal:  Transl Psychiatry       Date:  2020-12-01       Impact factor: 6.222

6.  MiRNA-873-5p Acts as a Potential Novel Biomarker and Promotes Cervical Cancer Progression by Regulating ZEB1 via Notch Signaling Pathway.

Authors:  Chen-Xia Wen; Hai-Li Tian; E Chen; Jin-Fang Liu; Xiao-Xing Liu
Journal:  Dose Response       Date:  2021-03-11       Impact factor: 2.658

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.